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Abstract
A review of published work in clinical natural language processing (NLP) may suggest that the negation detection task has
been ‘‘solved.’’ This work proposes that an optimizable solution does not equal a generalizable solution. We introduce a new
machine learning-based Polarity Module for detecting negation in clinical text, and extensively compare its performance
across domains. Using four manually annotated corpora of clinical text, we show that negation detection performance
suffers when there is no in-domain development (for manual methods) or training data (for machine learning-based
methods). Various factors (e.g., annotation guidelines, named entity characteristics, the amount of data, and lexical and
syntactic context) play a role in making generalizability difficult, but none completely explains the phenomenon.
Furthermore, generalizability remains challenging because it is unclear whether to use a single source for accurate data,
combine all sources into a single model, or apply domain adaptation methods. The most reliable means to improve
negation detection is to manually annotate in-domain training data (or, perhaps, manually modify rules); this is a strategy
for optimizing performance, rather than generalizing it. These results suggest a direction for future work in domain-adaptive
and task-adaptive methods for clinical NLP.
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Introduction
Negation in unstructured clinical text is a well-known phenom-
enon. It is crucial for any practical interpretation of clinical text,
since negation is common in clinical narrative. For example, the
medical significance of ‘‘no wheezing’’ is quite different from that
of ‘‘wheezing.’’ With the increasingly widespread use of electronic
medical records (EMRs), computational methodologies for nega-
tion detection have also become well-known, most notably the
early and strikingly straightforward NegEx algorithm [1]. In
NegEx, simple regular expressions yield solid performance on
detecting the negation of Findings, Diseases, and Mental or
Behavioral Dysfunctions from the Unified Medical Language
System (UMLS). The success of NegEx (and other techniques) is
attributable to the constrained pragmatics of clinical text: because
physicians are writing the text in order to convey the health status
of a patient, there is a limit to the ways that medically pertinent
concepts can be negated. Since existing algorithms have
performed well in many published studies [2–8], many clinical
natural language processing (NLP) practitioners consider negation
detection a solved problem (see Table 19s summary of Related
Work) with a simple, generalizable solution.
However, our present work will show that this ‘‘solved’’
designation is premature because current solutions are easily
optimizable but not necessarily generalizable. Negation detection is
still a challenge when considered from a practical, multi-corpus
perspective, i.e., one in which an algorithm is deployed in many
clinical institutions and on many sources of text. For simplicity in
this article, we will consider each corpus as its own ‘‘domain,’’
though we recognize that each corpus bridges multiple medical
subdomains and all sources that we consider consist only of clinical
text.
As the NLP Attribute Discovery team for the Strategic Health
IT Advanced Research Project on the Secondary use of the EHR
(SHARPn), we attempted to detect negation in four corpora, using
machine learning, rules, domain adaptation, and various evalua-
tion scenarios. These corpora include the new SHARPn NLP
Seed Corpus of clinical text with multiple layers of syntactic and
semantic information, including named entities (NEs) and polarity
(i.e., negation). We also used the 2010 i2b2/VA NLP Challenge
corpus, the MiPACQ corpus, and the NegEx Test Set. The
SHARPn Polarity Module used in our evaluation is currently
available in Apache cTAKES (clinical Text Analysis and
Knowledge Extraction System; ctakes.apache.org) as part of the
ctakes-assertion project, including an integrated domain adapta-
tion algorithm [9]. cTAKES is a comprehensive clinical NLP tool
based on the Unstructured Information Management Architecture
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and negation detection.
We conclude that practical negation detection is not reliable
without in-domain training data and/or development. Thus, it can
be optimized for a domain, but is difficult to generalize across
domains. ‘‘Benchmark’’ gold standard data sets differed sufficiently
to have a profound effect on the viability of negation detection
algorithms. Furthermore, it is difficult to determine an optimal mix
of training data, or to standardize a definitive ‘‘benchmark’’
metric, since both are influenced by corpus-specific annotation
guidelines and data sources. The results we report here should
remind users of negation detection algorithms to be vigilant in
tuning systems to their data, whether by training with local data or
modifying rules. We also call for future work in domain-adaptive
and task-adaptive methods.
After a discussion of the extensive related work in negation
detection, the remainder of this article will introduce the data and
methods for corpus and system comparisons of negation detection,
present the resulting performance of systems on the different
corpora, and discuss implications for negation detection and
annotation schema in the larger picture of clinical informatics.
Related Work
Negation has been studied philosophically since the time of
Aristotle; computational efforts addressing negation and related
evidentiality/belief state issues have surfaced much more recently
[10]. In the clinical domain, negation detection was a very
practical early motivation for NLP adoption among the informat-
ics community, and thus significant effort has gone into this task.
While there have been many systems implementing negation
detection, publicly available corpora for testing them are limited
by patient privacy concerns, as is typical in clinical NLP.
Negation detection systems have shown excellent performance
in clinical text, beginning with the rule-based NegEx algorithm
[1]. NegEx was originally evaluated on spans of text that matched
UMLS Findings, Diseases, and Mental or Behavioral Dysfunctions
among 1000 test sentences sampled from discharge summaries at
the University of Pittsburgh Medical Center; a regression test set
was released later with de-identified notes of 6 different types.
NegEx has produced numerous updated and customized systems
[11,12], including the updated version released with ConText [13]
which performed well on a benchmark NegEx Test Set (available
at https://code.google.com/p/negex/wiki/TestSet). Our tests
used the YTEX (Yale cTAKES Extensions) version of NegEx
[14] as a baseline and included the NegEx Test Set as a
benchmark.
Similar to NegEx, many other negation algorithms take a rule-
based approach, with a variety of techniques: lexical scan with
context free grammar [6], negation ontology [3], or dependency
parse rules [7]. Some negation algorithms treat the problem as a
machine learning classification task [4] or as some hybrid between
rules and machine learning [2,5]. The performance of these
systems and their data sources is summarized in Table 1 below.
All these general approaches were represented in the 2010
i2b2/VA NLP Challenge task on assertions [8]. In addition to
catalyzing innovation from multiple systems, this shared task
produced a benchmark data set that is available for research with a
simple data use agreement; it interprets negation on medical
problem NEs as an assertion that the problem is absent.
The four corpora used in our study all annotate named entities
explicitly; here, we consider named entities to be spans of text that
refer to real-world entities or events that may or may not be
classified or mapped to some external ontology. These corpora do
not explicitly include the scope of negation indicators – i.e., the
maximum span within a negation cue word could be applicable..
Some efforts have reversed this, giving an implicit notion of named
entities but an explicit notion of negation scope: notably the
BioScope Corpus [15] that was used as part of the CoNLL 2010
Shared Task [16]. Bioscope annotates negation, uncertainty, and
their scopes on de-identified clinical free text (1,954 radiology
reports), biological full articles (9 articles from FlyBase and BMC
Bioinformatics), and scientific abstracts (1,273 abstracts also in the
GENIA corpus). This is in contrast to the work we present here,
which focuses on named entities. We ignore scope for two reasons:
First, the lack of gold standard named entity mentions is an
additional source of error that no other corpus would have,
making the comparison unfair. Second, while negation scope
annotations overcome some recall issues for non-standard
terminology (e.g., ‘‘patient is not feeling as much like a pariah
today’’ would represent negation correctly despite finding no NE),
they do not overcome issues in fine-grained annotation guideline
distinctions (see Section 3.3 on Annotation Guidelines).
Methods
Here, we first describe the annotated NLP corpora used in
training and testing, with salient information about the gold
standard entity and negation annotation guidelines. We then
describe the new SHARPn Polarity Module and the YTEX
NegEx rule-based baseline.
3.1 Ethics statement
We did not seek IRB approval as all the data used in this study
were collected from previous studies. While the data sets were
from electronic medical records that originally included protected
health information, all medical records were reliably de-identified
Table 1. Extensive successful previous work on negation detection in clinical text.
Algorithm Data source Entities Method Prec. Rec. F1
Negfinder [6] 10 surgery notes & discharge summaries UMLS concepts Lexical/syntax rules 91.84 95.74 92.96
NegEx [1] UPMC ICU discharge summaries clinical conditions Trigger/scope rules 84.49 77.84 80.35
Neg assignment grammar [3] Hopkins HNP notes SNOMED concepts Negation ontology 91.17 97.19 93.90
Neg. Detection Module [5] Stanford radiology reports unmapped text phrases Regex/syntax rules 98.63 92.58 94.91
ConText [13] UPMC 6 note types clinical conditions Trigger/scope rules 92 94 93
MITRE assertion [2] 2010 i2b2/VA ‘‘problem’’ phrases Cue words, CRFs 92 95 94
DepNeg [7] Mayo clinical notes symptoms & diseases Dependency path rules 96.65 73.93 83.78
doi:10.1371/journal.pone.0112774.t001
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had access to any patient identifying information. Three of the
corpora (the SHARPn corpus, MiPACQ corpus, and i2b2 corpus)
were available to us with signed Data Use Agreements between the
supplier and recipient institutions. One (the NegEx Test Set) was
freely downloadable online with no restrictions.
3.2 NLP corpora with negation annotations
Our work used four clinical NLP annotation efforts; the
SHARPn NLP Seed Corpus, the 2010 i2b2/VA NLP Challenge
Corpus; the MiPACQ corpus; and the NegEx Test Set. Statistics
in Table 2 show their overall relative sizes, train/test splits, and
proportion of negated concepts.
First, the SHARPn NLP Seed Corpus consists of de-identified
radiology notes related to Peripheral Arterial Disease (PAD) from
Mayo Clinic, and de-identified breast oncology progress notes
regarding incident breast cancer patients from Group Health
Cooperative. This multi-layered annotated corpus follows com-
munity adopted standards and conventions for the majority of
annotation layers, which include syntactic trees, predicate-
argument structure, coreference, UMLS named entities, UMLS
relations, and Clinical Element Models (CEM) templates [17].
Negation is included in the CEM templates as an attribute of
UMLS concepts.
Second, the 2010 i2b2/VA NLP Challenge Corpus contained
manually annotated, de-identified reports from Partners Health-
care, Beth Israel Deaconess Medical Center, and the University of
Pittsburgh Medical Center. The majority of notes were discharge
summaries, but the University of Pittsburgh Medical Center also
contributed progress notes.
Third, the MiPACQ corpus [18,19] annotates multiple
syntactic and semantic layers, similar to the SHARPn NLP
corpus. There are three major divisions to the sources of data: a
snapshot of Medpedia articles on medical topics, written by
clinicians, retrieved on April 26, 2010; clinical questions from the
National Library of Medicine’s Clinical Questions corpus (http://
clinques.nlm.nih.gov), collected by interviews with physicians; and
sentences from Mayo Clinic clinical notes and pathology notes
related to colon cancer.
Finally, the NegEx Test Set is a set of manually-selected
sentences from 120 de-identified University of Pittsburgh Medical
Center reports (20 each of radiology, emergency department,
surgical pathology, echocardiogram, operative procedures, and
discharge summaries). This set was used to evaluate the ConText
algorithm [13], while another 120 reports of similar distribution
(not publically available) were used for the development of the
negation portion of ConText (i.e., an updated NegEx).
3.3 Comparison of annotation guidelines
Manually annotated negation in one of these corpora is not
strictly equivalent to that in other corpora. We cannot directly
compare annotation guidelines because we do not have corpora
that are multiply-annotated with different guidelines. However, we
should note that all annotation projects reported high inter-
annotator agreement within their respective projects. Here, we
qualitatively analyze the annotation guidelines concerning the
annotation of both NEs (concepts) and attributes (assertion status),
hypothesizing that some differences in annotation guidelines may
negatively affect the performance of negation algorithms across
corpora.
The primary difference between the annotation guidelines of
the corpora appears to be in the definition of NEs, rather than
direct indications of how negation should be handled. First, NE
annotation guidelines differ in the semantic types that are allowed.
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Semantic Groups. (However, in practice, some semantic groups
have zero or negligible frequencies, and we have grouped them
together in our analysis.) SHARP only annotates the 6 most
clinically relevant groups, namely, Diseases and Disorders, Signs
and Symptoms, Labs, Medications, Procedures, and Anatomical
Sites. These semantic group divisions and their respective
distributions are enumerated in Table 3, for these two corpora.
The NegEx Test Set is much more narrow, including only Signs,
Symptoms, Diseases, and Findings (but not differentiating between
these) with qualitative values. The i2b2 corpus is similarly
restrictive, only annotating ‘‘problems,’’ i.e., Diseases, Signs and
Symptoms. Thus, they are excluded from Table 3.
The corpora also differ in the span to consider when identifying
NEs. NegEx Test Set is the most permissive, annotating whole
clinically-relevant phrases as NEs regardless of their syntactic type
(e.g., the statement ‘‘Right ventricular function is normal’’ is
treated as a single entity as shown by the underlining). i2b2/VA
guidelines only consider whole noun and adjective phrases as
possible NEs (e.g., ‘‘her shortness of breath and coughing
resolved’’ includes the modifier ‘‘her’’ in the NE). Similar to
i2b2/VA, MiPACQ also indicates that whole noun phrases should
be candidate NEs, but smaller units are typically used in practice
(e.g., ‘‘her chest x-ray’’ leaves out the modifier ‘‘her’’). SHARP
predominantly annotates maximal strings that match UMLS terms
as NEs, which often excludes long paraphrases and closed-class
modifying adjectives (similar to MiPACQ), although there are
some cases of CUI-less NEs and multi-span NEs.
Another difference in NE annotation guidelines is the amount of
overlap allowed between NEs. The NegEx Test Set has only one
phrase annotated per sentence, hence no overlap in NEs; i2b2/VA
only annotates full noun and adjective phrases, so fully subsumed
NEs are not allowed. In contrast, SHARP annotates subspans as
long as they are mapped from the UMLS and of a different
semantic type (e.g., both ‘‘chest’’ (anatomical site) and ‘‘chest x-
ray’’ (procedure) in ‘‘her chest x-ray’’). MiPACQ removes this
restriction of different semantic types, but stipulates that some
relationship must be shared between the subspan and the full span
– this is in practice very similar to SHARP (e.g., there is a
locationOf relationship between ‘‘chest’’ and ‘‘chest x-ray’’).
Overall, the four guidelines are not as precise with negation
annotation definitions as they are with NEs. The SHARP,
MiPACQ, and NegEx Test Set representations imply a relation
between an explicit negation marker and the negated term (e.g., a
cue word like ‘‘no’’ would be marked, and the following term
‘‘shortness of breath’’ would then set a negation_indicator=pre-
sent). The i2b2/VA guideline assumes a pragmatic inference
about the intent of the author in describing his/her observations
(e.g., ‘‘no shortness of breath’’ would mark assertion=absent
without marking the cue word). This difference does lead to some
minor morphology-related annotation differences. For example,
‘‘afebrile’’ is marked as ‘‘absent’’ for i2b2, but not in SHARP,
MiPACQ, or NegEx Test Set since there is no external negation
indicator.
3.4 SHARPn Polarity Module
As with many existing approaches, the SHARPn Polarity
module treats negation detection as a classification problem for
NEs. We engineered features that would make sense of the context
surrounding an NE:
A. Token in Bag-of-Words (BOW). These most basic,
binary features indicated whether a given word appeared
within a window (bag) from the NE. For example, one feature
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We included several different BOWs, based on directionality
(preceding vs. following the NE) and size (3, 5, or 10).
B. Token in positional context. These features are similar to
BOW features, but are specific to the exact position with
respect to the NE of interest (e.g., ‘‘without’’ occurred 4
words preceding the NE). Windows of 4 and 5 were
considered.
C. Cue words. Following MITRE’s successful negation
detection system [2], we identified cue words – an expert-
curated list of negation-related words (e.g., ‘‘negative for’’).
The nearest cue word in scope and its category (a normalized
word or phrase, e.g., ‘‘negative’’) were included as binary
features.
D. Dependency path rules. We directly utilized the rule-
based DepNeg system [7] to produce binary features
corresponding to whether the NE lay along a dependency
path that typically specifies negation. For example, ‘‘no
evidence of coughing, rales, or wheezing’’ has ‘‘wheezing’’
outside a 5-word window, but is connected by a dependency
parse path to ‘‘no.’’
E. Constituency tree fragments. In addition to dependency
path rules, we also used constituency tree fragments. The
constituent parser within cTAKES is Ratnaparkhi’s Maxi-
mum Entropy parser [20] as implemented in OpenNLP,
trained on clinical treebanks. Tree fragments (partial
constituency trees) can represent, for example, that the NE
in question sits inside an adjective phrase ‘‘negative for ,
concept..’’ Fragments are automatically extracted and
defined following Pighin and Moschitti [21]; training data
determines whether the features are useful or not.
Examples of these features are included in a table in the
Discussion section. The size of the feature set is upper-bounded by
the size of the training set’s vocabulary and diversity of tree
fragments; there are 12 dependency path rules. In practice, a
feature vector, v, will be smaller than this upper bound, since not
every dictionary word is in the context of an NE.
The SHARPn Polarity Module classifies each NE based on
these features. We chose to utilize classifiers via ClearTK because
of its compatibility with UIMA-based systems like cTAKES [22].
After some preliminary experimentation with various classifiers,
we selected linear kernel SVMs implemented with LIBLINEAR,
which learn decision boundaries (negated vs. not negated) based
on the distribution of features in the training data. SVMs are
considered to have good generalization performance due to
inherent regularization, and excel in situations (like ours) where
there are a massive number of features. Since linear kernel SVMs
require only one parameter to be tuned, we manually tuned it
during development using cross-validation.
Training data for a single model can consist of more multiple
corpora. In a standard setting, instances from different corpora
would not be differentiated during training. Alternatively, we
implemented an optional domain adaptation algorithm, frustrat-
ingly easy domain adaptation (FEDA) [9], to build some of our
multi-corpus models. FEDA is a simple but effective domain
adaptation technique that requires in-domain training data. If
there are data from four domains a, b, c, and d, for example, a
model would be trained with 5 concatenated (row) feature vectors:
v=[vall va vb vc vd ]. A training sample from domain a will be
logged in vall and va only, whereas a training sample from from
domain b will be logged in vall and vb only, and so forth. At test
time, the domain of the test sample is supplied to the classifier, and
instances are classified with a weighting of the domain-specific
model in concert with the ‘‘general’’ model.
3.5 Evaluation Setup
Our evaluations used the NegEx algorithm as a baseline, as
implemented in the Yale cTAKES Extensions (YTEX) [14]. Using
Named Entities discovered by the standard cTAKES pipeline, the
YTEX negation module set the ‘‘polarity’’ attribute of each NE to
21 (negated) or +1 (not negated). Because NegEx is a rule-based
method, we would expect it to be immune to performance
improvement or degradation based on training data. However, it
is well-known that customization of rules is likely necessary when
applying NegEx in settings other than the one in which it was
initially developed [11,12].
The SHARPn Polarity module was implemented within the
cTAKES system (see Figure 1), leveraging feature extraction and
machine learning programming interfaces available in the
ClearTK suite of tools (available at https://code.google.com/p/
cleartk/). It should be noted that we did preliminary tests using x
2
feature selection (filtering out the feature if their x
2 values were too
low), but the performance did not significantly improve. Thus, we
have left feature selection out of the results of this study; some
sample x
2 values for specific features are listed in the Discussion
section. The polarity module used in our tests is currently available
as a tagged branch of the Apache cTAKES source code
repository, and will be part of a future cTAKES release.
For both training and testing, we used gold standard NEs and
negation annotations as defined in each of the corpora. System
negation annotations are compared to gold standard for precision,
recall, and F-measure (the harmonic mean of precision and recall).
We also used the default cTAKES pipeline to produce anything
besides NEs or negation annotations (e.g., sentence annotations,
tokens, POS tags, dependency parses, constituency parses,
semantic role labels; see ). While there is some risk for error
propagation from these other components into negation detection,
we believe this risk is minimized for the main precision, recall, and
F-measure metrics, because systemic errors would appear in both
training and testing data, and any impact on negation perfor-
mance would be mediated through their representation in a
machine learning feature vector.
We trained the SHARPn Polarity module on each of the four
corpora; train/test splits were provided for the SHARPn, i2b2/
VA, and MiPACQ corpora; for these three corpora, training and
testing in our evaluations uniformly respected these training and
testing splits (e.g., even in cases like training on SHARP data but
testing on i2b2 data). Because the NegEx Test Set’s corresponding
development set was not available, we used the NegEx Test Set in
any single evaluation as either the training data or the testing data.
The tables presenting our results use parantheses to show when
reusing training data invalidates the test performance measures
(i.e., training and testing would have been on the same data).
Results
4.1 Single test corpus performance
The practical question a user might ask is: ‘‘How can I
maximize negation detection performance for my data?’’ Table 4
below illustrates the difficulty of answering this question by
showing performance on four corpora (columns) by various
systems (rows). Row 0 gives previously reported comparison
statistics for i2b2 data (MITRE [2]) and the NegEx TestSet
(GenNegEx 1.2.0, see https://code.google.com/p/negex/wiki/
TestSet); SHARP and MiPACQ do not have previous results to
compare with. We have grouped these systems to be representative
Generalizability vs. Optimizability in Clinical Negation Detection
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community: the unedited, rule-based YTEX algorithm (row 1);
machine learning classifiers when only out-of-domain data (OOD)
is available (rows 2–6); and machine learning classifiers when some
in-domain data is available (rows 7–9). Note that row 7 is
equivalent to the diagonal from rows 2–6, namely, where the
training set and test set are from (different portions of) the same
corpus. Table 4 also includes significance bands down each
column; pair-wise approximate randomization significance tests
for F1 score, aggregated by document, are reported for p,0.05.
Values in a column labeled with different successive superscripted
letters (e.g., 93.9
a and 92.6
b) indicate that there is a significant
difference between two systems. These bands are further visualized
in Figure 2.
First, YTEX (top row), implementing the widely used rule-based
NegEx algorithm, performed quite well on the NegEx Test Set
(F1=95.3%). When used without modification on other corpora,
performance fell to unacceptable levels (e.g., F1=62.3% on
SHARP data). As might be expected, we may conclude that
widely-used rule-based algorithms need to be modified according
to their target data.
For situations in which only OOD data is available (common in
clinical text), one strategy is to use a single OOD corpus as training
data (rows 2–5). Using a single OOD corpus has widely varying
results, with models ranging from 59.3% to 95.4% F-score on the
NegEx Test Set. Another strategy is to ‘‘use all the (OOD) data
you have’’ (row 6), but again the results are mixed. With the
highest OOD models in bold, it is not clear which strategy is
optimal, and it is difficult to tell what pairs of corpora yield good
performance. Underlying reasons for this variability are further
explored in Section 4.2.
The situation is much improved when in-domain data is
available (rows 7–9, with most scores lying within the highest
significance band, labeled with superscript ‘a’). Only in MiPACQ
data, for which the test set is small, are there OOD models in the
same significance bands (i.e., superscript ‘a’ in rows 2–6) as the
best models with in-domain data. With in-domain models, we still
face the same problem of whether to use a single in-domain corpus
(row 7) or to ‘‘use all the data you have’’ (row 8). Only in i2b2 data
are improvements statistically significant, and which approach
performs better appears to differ by corpus. It may be the case
that, since i2b2 data is only on ‘problems,’ including training data
Figure 1. The cTAKES Pipeline. The SHARPn Polarity Module is an Attribute Discovery algorithm. Training and evaluations use gold standard NEs
(skip NER).
doi:10.1371/journal.pone.0112774.g001
Figure 2. Significance bands of model performance for each test corpus. These are labeled with successive letters from right to left in
Table 4.
doi:10.1371/journal.pone.0112774.g002
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being the most general, appears to benefit from training on other
corpora.
Using domain adaptation (row 9) is also not conclusively better
than a single in-domain corpus (row 7) or leaving out domain
adaptation (row 8), since improvements are not statistically
significant at the p,0.05 level (all share ‘a’ superscripts). Recall
that these ‘‘All+FEDA’’ tests (row 9) will train a model with a
feature space approximately 5 times the size of the ‘‘All’’ feature
spaces (row 8). Without conclusive evidence, it is difficult to say
whether the additional model complexity is worth it.
Thus, whether there is in-domain data available or not, we
cannot conclude a uniform policy such as ‘‘use all available data to
train your model’’ or ‘‘train a model on a single most similar
corpus’’ or ‘‘always use domain adaptation if possible.’’ However,
we can conclude that annotating in-domain data is the best way to
ensure solid performance on a machine learning system. Note that,
this is a method of optimizing the performance for a corpus, rather
than generalizing performance between corpora.
4.2 Corpus difficulty and usefulness
Rather than trying to define an arbitrary scientific measure of
corpus ‘similarity,’’ we consider the practical perspectives of
corpus ‘‘difficulty’’ (scores on testing, down columns) and
‘‘usefulness’’ (scores on training, along rows). As evidenced by
the OOD rows 2–5 of Table 4, the difficulty and usefulness of
corpora seem to vary. Testing on MiPACQ data has an average F1
score of 70.9% down the column of trained systems, indicating it is
probably the most difficult to test on. Training on i2b2 data (row
3) achieved a macro-averaged F1 score of 80.7% across the row of
test sets, indicating its training set is perhaps the single most useful
for training.
Difficulty and usefulness are not symmetric: i2b2 data is clearly
the best OOD training data for the NegEx Test Set (F1=95.4% in
column 4); but NegEx is not the best OOD training data for the
i2b2 test set (F1=81.1% in column 2; MiPACQ is significantly
better with F1=82.6%). These variations in difficulty and
usefulness could hypothetically be explained by several factors.
For example, the diversity of source data in the MiPACQ corpus
(including non-clinical data such as Medpedia) may contribute to
its difficulty; MiPACQ in-domain performance is loosely compa-
rable to the OOD performance of other models. Additionally,
Section 4.4 below explores differences in the annotation guidelines
(as expressed in NE length and semantic group). Different corpora
have fundamentally different characteristics, and more samples
from one corpus are not equal to those from another.
We also sought determine whether usefulness could be
explained by corpus size, hypothesizing that more data would
lead to more robust machine learning models. Thus we performed
experiments in which the amount of training data was varied.
These experiments focus on the i2b2 training data which had a
small but consistent advantage in cross-domain experiments. We
built learning curves in which we tested on the SHARP Seed,
MiPACQ, and i2b2 test sets. We randomly sampled from 10% to
100% of the training data, at increments of 10%. For each
sampled proportion size we averaged across 5 runs to compute F-
scores at that point.
The results are shown in Figure 3. The learning curve for the
i2b2 data seems to be increasing even until the very end, as the
classifier seems to be making marginal improvements with ever
more data. In contrast, in both cross-domain experiments the
performance levels off very early, conservatively estimated at
around 20% of the i2b2 training data being used. For additional
reference, we have also plotted two points taken from Table 4– the
in-domain performance for SHARP and Mipacq. The x-axis for
each of these points is the size of the training data (counted as the
number of instances of negation), while the y-axis is the F-score
obtained on each corpus’ in-domain evaluation.
These experiments seem to indicate that the value of the i2b2
corpus is not simply because of its size. In fact, performance on
outside corpora of a system trained on 20% of the i2b2 data is
comparable to one trained on 100%.
We should be careful to not overstate the distinctions of ‘‘most
difficult’’ or ‘‘most useful.’’ Furthermore, overall ‘‘usefulness’’ does
not necessarily imply usefulness in a specific OOD setting or
corpus, for example, supplementing in-domain training data with
the ‘‘useful’’ corpus. In further testing on the SHARP corpus, we
considered whether the ‘‘useful’’ i2b2 training data could augment
the SHARP training data, and found that adding i2b2 training
data did not improve performance on the SHARP corpus
(F1=90.9%), whereas adding MiPACQ did improve performance
(F1=94.6%). Though it is difficult to define ‘‘similarity,’’ it may be
the case that more similar corpora can be mixed as training data
more effectively.
4.3 Average performance
We considered average performance of several models on
multiple corpora. In Table 5 we include averages with and
without FEDA (i.e., for rows 8–9 of Table 4), labeling pairwise
Table 4. Performance (F1 score) in practical negation detection situations.
Test sharp i2b2 mipacq negexts
Previous 0. (various) – 94 – 94.6
Rule-based 1. ytex (rules) 62.3
c 82.1
d 71.3
a,b 95.3
a
ML with out-of-domain (OOD) training 2. sharp 80.7
e 61.2
b 87.3
b
3. i2b2 74.7
b,c 71.9
a,b 95.4
a
4. mipacq 72.9
b,c 82.6
d 59.3
d
5. negexts 58.6
c 81.1
e 70.6
a,b
6. All 3 OOD 79.0
b 83.9
c 69.1
a,b 69.9
c
ML with in-domain training 7. 1 In-Domain 93.5
a 93.6
a 73.6
a,b (99.9)
8. All 4 corpora 89.7
a 92.6
b 75.3
a (69.9
c)
9. All+FEDA 97.9
a 93.9
a 73.9
a (58.0
d)
doi:10.1371/journal.pone.0112774.t004
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non-domain adapted versions with an asterisk. The NegEx Test
Set is used for training rather than testing.
Here, we report both macro-averages (arithmetic mean of the
three test sets) and micro-averages (weighted by the number of
instances in each test set). The micro-averaged scores are heavily
weighted towards the i2b2 numbers because the i2b2 test set is the
largest; macro-averages, on the other hand, are much lower than
has been previously reported in literature, in large part due to the
difficulty of the MiPACQ corpus. Overall, i2b2 is the only corpus
on which domain-adapted models clearly outperform un-adapted
models.
4.4 Named Entity characteristics
Negation predictions were further analyzed to see if the
differences in NE annotation guidelines influenced performance,
since resulting differences in ‘‘gold standard’’ training data could
confuse machine learning systems. Because guidelines for anno-
tating NEs differed in how much of a noun phrase to include, we
examined NE length in words. Figure 4 shows that the i2b2-
trained model has the best overall performance, likely due to its
larger number of training samples rather than its similarity to
other annotation guidelines. Underscoring this, the NegEx Test
Set is the most permissive guideline (allowing whole phrases), yet it
obtains similar performance to the restrictive SHARP and
MiPACQ guidelines (typically short phrases).
Figure 4 also shows that longer Named Entities are more
difficult to negate correctly in all of the corpora; in the i2b2 corpus,
single-word terms were easy to negate, whereas in other corpora
single-word terms were substantially harder. One hypothesis is
that this could be due to i2b2’s different accounting of inherently
negated terms such as ‘‘afebrile.’’ ‘‘Afebrile’’ itself accounted for
124 of 3,609 negated NEs in the i2b2 training set, and the number
Figure 3. Learning curve for i2b2 training data on various corpora. For each proportion of the i2b2 corpus (x axis), the reported F-score (y
axis) is an average of 5 randomly sampled runs.
doi:10.1371/journal.pone.0112774.g003
Table 5. Average F-score with and without frustratingly easy domain adaptation (FEDA).
Test \Train All + FEDA
sharp 89.66 97.87
i2b2 92.57 93.93*
mipacq 75.29 73.93
negex ––
macro-avg 85.84 88.58
micro-avg 91.91 93.28*
doi:10.1371/journal.pone.0112774.t005
Figure 4. The effect of named entity length (in number of
words) on performance for each of 6 training configurations.
SHARP, MiPACQ, and i2b2 test sets are used for evaluation.
doi:10.1371/journal.pone.0112774.g004
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suffixation or negative acronym component (e.g., ‘‘NAD’’ standing
for ‘‘no acute distress’’) total 299 (8.3%). While this does not
account for the total error difference in one-word NEs, it is a factor
worth noting. Additional annotation differences may result from
differing assumptions regarding explicit and implicit expression of
negations. Further accounting of these terms may require re-
annotation of the corpus, which is out of the scope of this article.
Because the annotation guidelines also differed in which
semantic groups to annotate, we considered performance of each
model for each specific semantic group, shown in Figure 5. Recall
from Table 3 that SHARP and MiPACQ included a broad
selection of semantic groups, including anatomical sites (ANAT),
chemicals and drugs (CHEM), disorders (DISO), laboratories
(LAB), procedures (PROC), and symptoms (SYMP). i2b2 and the
NegEx Test Set only specified ‘‘problems’’ and are considered
EVENT in Figure 5.
Despite their annotation guideline similarity, we did not find
that SHARP and MiPACQ performed similarly on individual
semantic groups. Note in particular the relatively low SHARP-
trained performance on ANAT, CHEM, PROC, and SYMP
despite its having training data in those groups. A MiPACQ-
trained model also did not outperform other models, despite that
most of the test set NEs of minority semantic groups came from
the MiPACQ corpus. Similarly, the i2b2-trained and NegEx Test
Set-trained models had similar annotation guidelines, but did not
perform similarly on groups such as EVENT, DISO, or PROC.
These models were not uniformly worse than SHARP or
MiPACQ on the semantic groups for which they had no training
data.
Discussion
5.1 Salient features
From the foregoing tests, NE properties like length and semantic
group (and thus, annotation guidelines) did not fully explain the
discrepancy in performance between different models. Thus, we
qualitatively examined the broader differences between corpora by
looking at negation contexts in each corpus. We defined negation
contexts as the features of the SHARPn Polarity Module, as
defined in Section 3.4.
Table 6 calculates and ranks the x
2 statistic corresponding to
each feature (i.e., on a 262 grid of whether the NE was negated vs.
whether the feature was present) within all four sets of training
data. Thus, the ranking in Table 6 corresponds to the model
trained on ‘‘All’’ training sets, in row 8 of Table 4 and in the
preceding section. Table 6 also compares the rank of features in
the ‘‘all’’ model to salient features in each individual corpus.
It is evident that the most important features were consistent
across all the corpora, representing the ‘‘easy cases’’ of negation:
namely, when the word ‘‘no’’ is related to a concept by proximity
or by syntax. The SHARP corpus differs somewhat, likely due to
the sources of data for the SHARPn Seed Corpus: Mayo Clinic
radiology reports (do not directly report a patient interaction) and
Seattle Group Health breast cancer-related notes (only one
example of a patient ‘‘denying’’ smoking). This distinction does
not explain why MiPACQ, rather than SHARP, is a more
‘‘difficult’’ corpus.
5.4 The Big Picture for Negation Detection
Because of the relatively constrained pragmatic uses of negation
in clinical text, negation detection algorithms are easy to optimize
for specific corpora, as illustrated in Table 1. However, we believe
the research community has at times conflated this with being
immediately effective off-the-shelf. Evaluation of systems is
artificially inflated by the ad hoc development of training and
testing corpora and their differing annotation guidelines. When in-
domain, consistently-annotated training data is scarce or nonex-
istent, negation detection performance remains unimpressive
(middle portion of Table 4), just as in other NLP problems like
parsing or named entity recognition. Furthermore, it is difficult to
simply characterize the differences between domains, e.g., by NE
length (Figure 4), semantic group (Figure 5) or lexical and
syntactic context (Table 6).
Figure 5. The effect of named entity semantic group on the F-score of 6 models. SHARP, MiPACQ, and i2b2 test sets are used for
evaluation.
doi:10.1371/journal.pone.0112774.g005
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learning model, it appears that we still need to annotate examples
of negation on the target corpus for fully supervised training (or
domain adaptation). Similarly, rule-based methods need a
development set and experts who can develop domain-specific
rules. Thus, we conjecture that negation is not ‘‘solved’’ until
negation is tailored to specific applications and use cases, or until
the more general problem of semi-supervised domain adaptation is
solved.
Conclusion
While a review of published work may suggest that the negation
detection task in clinical NLP has been ‘‘solved,’’ our multi-corpus
analysis of negation detection indicates that it is easy to optimize for
a single corpus but not to generalize to arbitrary clinical text.
Though negation detection can be straightforward in constrained
settings, both rule-based and machine-learning approaches have
mixed results in heterogeneous corpora. Furthermore, more
training data was not necessarily better for the common case in
which no in-domain data is available. The most significant
difference in performance was the availability of in-domain
training data, which is inherently a strategy for optimizing
performance rather than generalizing it. Furthermore, training
on all available data and using domain adaptation techniques did
not uniformly benefit performance in a significant way. Future
work includes task-adaptive negation detection algorithms and
semi-supervised domain adaptation.
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